Thrombin and protease-activated receptors (PARs) in atherothrombosis
暂无分享,去创建一个
Lina Badimon | L. Badimón | M. Gentile | J. Martínez-González | O. Calvayrac | C. Rodríguez | José Martínez-González | Lluis Martorell | Cristina Rodríguez | Maurizio Gentile | Olivier Calvayrac | L. Martorell
[1] A. Lumsden,et al. Characterization of thrombin receptor expression during vascular lesion formation. , 1994, Circulation research.
[2] A. Ridley,et al. Rho and Rac but not Cdc42 regulate endothelial cell permeability. , 2001, Journal of cell science.
[3] H. Shimizu,et al. Macrophage Migration Inhibitory Factor Is Induced by Thrombin and Factor Xa in Endothelial Cells* , 2004, Journal of Biological Chemistry.
[4] R. Paul,et al. Thrombin-induced force development in vascular endothelial cells: contribution to alteration of permeability mediated by calcium-dependent and -independent pathways. , 2005, Journal of pharmacological sciences.
[5] R. Chambers,et al. Thrombin Stimulates Smooth Muscle Cell Procollagen Synthesis and mRNA Levels via a PAR-1 Mediated Mechanism , 1998, Thrombosis and Haemostasis.
[6] K. Hirano,et al. Mechanism of endothelium-dependent relaxation induced by thrombin in the pig coronary artery. , 1998, European journal of pharmacology.
[7] J. Badimón,et al. Thrombin in arterial thrombosis. , 1994, Haemostasis.
[8] V. Fuster,et al. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation. , 1991, Blood.
[9] V. Fuster,et al. The Three Processes Leading to Post PTCA Restenosis: Dependence on the Lesion Substrate , 1995, Thrombosis and Haemostasis.
[10] L. B. Chen,et al. Mitogenic activity of blood components. I. Thrombin and prothrombin. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[11] D. Grigoryev,et al. Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. , 2004, American journal of respiratory cell and molecular biology.
[12] K. Schrör,et al. Evidence for functionally active protease‐activated receptor‐4 (PAR‐4) in human vascular smooth muscle cells , 2001, British journal of pharmacology.
[13] P. Halban,et al. Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[14] M. Yamakuchi,et al. HMG-CoA Reductase Inhibitors Inhibit Endothelial Exocytosis and Decrease Myocardial Infarct Size , 2005, Circulation research.
[15] T. Kietzmann,et al. Thrombin activates the p21-activated kinase in pulmonary artery smooth muscle cells , 2005, Thrombosis and Haemostasis.
[16] A. Habib,et al. Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: possible relevance to HIF‐1α , 2003, Journal of thrombosis and haemostasis : JTH.
[17] J. Lodder,et al. Thrombin-induced hyperactivity of platelets of young stroke patients: involvement of thrombin receptors in the subject-dependent variability in Ca2+ signal generation. , 2002, Thrombosis and haemostasis.
[18] R. Kaufman,et al. Intracellular trafficking of factor VIII to von Willebrand factor storage granules. , 1998, The Journal of clinical investigation.
[19] V. Fuster,et al. Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy. , 1994, Circulation.
[20] J. Nishimura,et al. Thrombin causes endothelium‐dependent biphasic regulation of vascular tone in the porcine renal interlobar artery , 2000, British journal of pharmacology.
[21] T. Lüscher,et al. Statin Prevents Tissue Factor Expression in Human Endothelial Cells: Role of Rho/Rho-Kinase and Akt Pathways , 2002, Circulation.
[22] J. Montani,et al. Thrombin Stimulates Human Endothelial Arginase Enzymatic Activity via RhoA/ROCK Pathway: Implications for Atherosclerotic Endothelial Dysfunction , 2004, Circulation.
[23] S. Steinberg. The Cardiovascular Actions of Protease-Activated Receptors , 2005, Molecular Pharmacology.
[24] C. Kanthou,et al. Variability in the proliferative responsiveness of cultured human vascular smooth muscle cells to α‐thrombin , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[25] P. Bongrand,et al. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). , 1998, Blood.
[26] J. Matsoukas,et al. Modulation of angiogenesis and progelatinase a by thrombin receptor mimetics and antagonists. , 2001, Endothelium : journal of endothelial cell research.
[27] M. D'Andrea,et al. Altered vascular injury responses in mice deficient in protease-activated receptor-1. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[28] Wei Huang,et al. Role of thrombin signalling in platelets in haemostasis and thrombosis , 2001, Nature.
[29] M. Bernatowicz,et al. Peptide-derived protease-activated receptor-1 (PAR-1) antagonists. , 2003, Current medicinal chemistry. Cardiovascular and hematological agents.
[30] L. Badimón,et al. The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells. , 2005, Cardiovascular research.
[31] S. Coughlin,et al. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. , 1993, The Journal of clinical investigation.
[32] A. Rothman,et al. Immediate-early gene expression in response to hypertrophic and proliferative stimuli in pulmonary arterial smooth muscle cells. , 1994, The Journal of biological chemistry.
[33] V. Fuster,et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. , 1997, Circulation.
[34] S. Basili,et al. Inhibition of tissue-factor-mediated thrombin generation by simvastatin. , 2000, Atherosclerosis.
[35] M. Kashgarian,et al. PECAM‐1 modulates thrombin‐induced tissue factor expression on endothelial cells , 2007, Journal of cellular physiology.
[36] K. Hirano. The roles of proteinase-activated receptors in the vascular physiology and pathophysiology. , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[37] A. Kuliopulos,et al. Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation , 2002, Nature Medicine.
[38] A. Kuliopulos,et al. Role of the PAR4 Thrombin Receptor in Stabilizing Platelet-platelet Aggregates as Revealed by a Patient with Hermansky-Pudlak Syndrome , 2002, Thrombosis and Haemostasis.
[39] C. Derian,et al. Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis , 2006, Circulation.
[40] M. Hollenberg,et al. Rapid Release of Matrix Metalloproteinase (MMP)-2 by Thrombin in the Rat Aorta: Modulation by Protein Tyrosine Kinase/Phosphatase , 1999, Thrombosis and Haemostasis.
[41] R. Nutt,et al. An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkey. , 1995, Circulation.
[42] W. Ruf,et al. Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.
[43] V. Fuster,et al. Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin. , 1998, Circulation.
[44] L. Case,et al. Combination of fosinopril and pravastatin decreases platelet response to thrombin receptor agonist in monkeys. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[45] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[46] S. Coughlin,et al. Protease‐activated receptors in hemostasis, thrombosis and vascular biology , 2005, Journal of thrombosis and haemostasis : JTH.
[47] C. Napoli,et al. Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions , 2004, Journal of Clinical Pathology.
[48] S. Meloche,et al. Rho Family GTPases Are Required for Activation of Jak/STAT Signaling by G Protein-Coupled Receptors , 2003, Molecular and Cellular Biology.
[49] N. Bunnett,et al. Protease-activated receptors: contribution to physiology and disease. , 2004, Physiological reviews.
[50] F. Giordano,et al. Antisense fosB RNA inhibits thrombin-induced hypertrophy in cultured pulmonary arterial smooth muscle cells. , 1998, Circulation.
[51] A. Malik,et al. Thrombin receptor 14-amino acid peptide mediates endothelial hyperadhesivity and neutrophil adhesion by P-selectin-dependent mechanism. , 1992, Circulation research.
[52] S. Coughlin,et al. Protease-activated receptor 3 is a second thrombin receptor in humans , 1997, Nature.
[53] R. Jain,et al. Kruppel-Like Factor 2 Inhibits Protease Activated Receptor-1 Expression and Thrombin-Mediated Endothelial Activation , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[54] C. Wiedermann,et al. Rho-GTPase–Dependent Platelet-Neutrophil Interaction Affected by HMG-CoA Reductase Inhibition With Altered Adenosine Nucleotide Release and Function , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[55] P. Noris,et al. Reversal of Thrombin-Induced Deactivation of CD39/ATPDase in Endothelial Cells by HMG-CoA Reductase Inhibition: Effects on Rho-GTPase and Adenosine Nucleotide Metabolism , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[56] Nagadhara Dronadula,et al. A Novel Role for Nuclear Factor of Activated T Cells in Receptor Tyrosine Kinase and G Protein-coupled Receptor Agonist-induced Vascular Smooth Muscle Cell Motility* , 2004, Journal of Biological Chemistry.
[57] John G. Collard,et al. Activation of RhoA by Thrombin in Endothelial Hyperpermeability: Role of Rho Kinase and Protein Tyrosine Kinases , 2000, Circulation research.
[58] Thiennu H. Vu,et al. Thrombin receptor expression in normal and atherosclerotic human arteries. , 1992, The Journal of clinical investigation.
[59] K. Takeda,et al. cAMP Response Element–Binding Protein Mediates Thrombin-Induced Proliferation of Vascular Smooth Muscle Cells , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[60] J. Wallace,et al. Agonists of proteinase‐activated receptor 1 induce plasma extravasation by a neurogenic mechanism , 2001, British journal of pharmacology.
[61] N. Tsopanoglou,et al. On the Mechanism of Thrombin-induced Angiogenesis , 1999, The Journal of Biological Chemistry.
[62] V. Fuster,et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. , 1994, Journal of the American College of Cardiology.
[63] G. Vilahur,et al. Differential intracellular trafficking of von Willebrand factor (vWF) and vWF propeptide in porcine endothelial cells lacking Weibel-Palade bodies and in human endothelial cells. , 2003, Atherosclerosis.
[64] S. Kondo,et al. [Antithrombin III and heparin cofactor II]. , 1985, Rinsho byori. The Japanese journal of clinical pathology.
[65] S. Coughlin,et al. Protection against thrombosis in mice lacking PAR3. , 2002, Blood.
[66] B. Tesfamariam. Thrombin receptor-mediated vascular relaxation differentiated by a receptor antagonist and desensitization. , 1994, The American journal of physiology.
[67] S. Coughlin,et al. A Role for Thrombin Receptor Signaling in Endothelial Cells During Embryonic Development , 2001, Science.
[68] D. Collen,et al. Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[69] V. Fuster,et al. Platelet Deposition Induced by Severely Damaged Vessel Wall Is Inhibited by a Boroarginine Synthetic Peptide with Antithrombin Activity , 1994, Thrombosis and Haemostasis.
[70] D. Ku,et al. Receptor Mechanism of Thrombin‐Induced Endothelium‐Dependent and Endothelium‐Independent Coronary Vascular Effects in Dogs , 1993, Journal of cardiovascular pharmacology.
[71] Chin‐Chung Wu,et al. The role of PAR4 in thrombin-induced thromboxane production in human platelets , 2003, Thrombosis and Haemostasis.
[72] M. D'Andrea,et al. Blockade of the Thrombin Receptor Protease-Activated Receptor-1 with a Small-Molecule Antagonist Prevents Thrombus Formation and Vascular Occlusion in Nonhuman Primates , 2003, Journal of Pharmacology and Experimental Therapeutics.
[73] L. Badimón,et al. Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells. , 1997, Atherosclerosis.
[74] S. Chackalamannil. Thrombin receptor (protease activated receptor-1) antagonists as potent antithrombotic agents with strong antiplatelet effects. , 2006, Journal of medicinal chemistry.
[75] K. Hirano,et al. Stimulus‐specific alteration of the relationship between cytosolic Ca2+ transients and nitric oxide production in endothelial cells ex vivo , 2000, British journal of pharmacology.
[76] W. Aird,et al. Thrombin Stimulation of Vascular Adhesion Molecule-1 in Endothelial Cells Is Mediated by Protein Kinase C (PKC)-δ-NF-κB and PKC-ζ-GATA Signaling Pathways* , 2003, The Journal of Biological Chemistry.
[77] G. Cottrell,et al. Protease-activated receptor 2: activation, signalling and function. , 2003, Biochemical Society transactions.
[78] W. Aird,et al. Thrombin-induced Autoinhibitory Factor, Down Syndrome Critical Region-1, Attenuates NFAT-dependent Vascular Cell Adhesion Molecule-1 Expression and Inflammation in the Endothelium* , 2006, Journal of Biological Chemistry.
[79] D. McKemy,et al. Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. , 2003, Blood.
[80] M. Benezra,et al. Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action. , 1990, Cell regulation.
[81] N. Tsopanoglou,et al. On the mechanism of thrombin-induced angiogenesis: inhibition of attachment of endothelial cells on basement membrane components , 1997, Angiogenesis.
[82] Y. Takada,et al. Plasmin-induced Migration Requires Signaling through Protease-activated Receptor 1 and Integrin α9β1* , 2004, Journal of Biological Chemistry.
[83] V. Fuster,et al. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. , 1999, Circulation.
[84] S. Klarenbach,et al. Differential Actions of PAR2 and PAR1 in Stimulating Human Endothelial Cell Exocytosis and Permeability: The Role of Rho-GTPases , 2003, Circulation research.
[85] Chunxiang Zhang,et al. Blockade of Nuclear Factor of Activated T Cells Activation Signaling Suppresses Balloon Injury-induced Neointima Formation in a Rat Carotid Artery Model* , 2005, Journal of Biological Chemistry.
[86] Robert V Farese,et al. A dual thrombin receptor system for platelet activation , 1998, Nature.
[87] Bridget Wilcken,et al. The pathogenesis of coronary artery disease , 1976 .
[88] J. Lankelma,et al. Simvastatin Improves Disturbed Endothelial Barrier Function , 2000, Circulation.
[89] M. O’Donnell,et al. Update on Antithrombotic Therapy: New Anticoagulants , 2010, Circulation.
[90] Martínez‐González,et al. The response of smooth muscle cells to α‐thrombin depends on its arterial origin: comparison among different species , 1998, European journal of clinical investigation.
[91] Chin‐Chung Wu,et al. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation. , 2006, European journal of pharmacology.
[92] L. Badimón,et al. Human and porcine smooth muscle cells share similar proliferation dependence on the mevalonate pathway: implication for in vivo interventions in the porcine model , 1996, European journal of clinical investigation.
[93] S. Karpatkin,et al. Thrombin induces neoangiogenesis in the chick chorioallantoic membrane , 2003, Journal of thrombosis and haemostasis : JTH.
[94] M. Vidaud,et al. The angiopoietin pathway is modulated by PAR‐1 activation on human endothelial progenitor cells , 2006, Journal of thrombosis and haemostasis : JTH.
[95] A. Leger,et al. Protease-Activated Receptors in Cardiovascular Diseases , 2006, Circulation.
[96] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.
[97] S. Coughlin,et al. PAR3 is a cofactor for PAR4 activation by thrombin , 2000, Nature.
[98] M. Hirano,et al. Involvement of Gi/o in the PAR-4-induced NO production in endothelial cells. , 2006, Biochemical and biophysical research communications.
[99] L. Badimón,et al. Influence of statin use on endothelial function: from bench to clinics. , 2007, Current pharmaceutical design.
[100] W. Ruf,et al. Role of Protease Activated Receptor 1 and 2 Signaling in Hypoxia-Induced Angiogenesis , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[101] S. Coughlin,et al. Thrombin signalling and protease-activated receptors , 2000, Nature.
[102] L. Badimón,et al. Heterogeneity of smooth muscle cells in advanced human atherosclerotic plaques: intimal smooth muscle cells expressing a fibroblast surface protein are highly activated by platelet‐released products , 2001, European journal of clinical investigation.
[103] L. Brass. Thrombin and platelet activation. , 2003, Chest.
[104] M. D'Andrea,et al. Increased Expression of Protease Activated Receptor-2 (PAR-2) in Balloon-Injured Rat Carotid Artery , 1999, Thrombosis and Haemostasis.
[105] T. Lindahl,et al. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development , 2007, Thrombosis and Haemostasis.
[106] Y. Iwamoto,et al. Rac1 Regulation of Surface Expression of Protease-Activated Receptor-1 and Responsiveness to Thrombin in Vascular Smooth Muscle Cells , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[107] S. Coughlin,et al. Protease-activated Receptor-1 Down-regulation , 2000, The Journal of Biological Chemistry.
[108] V. Wheaton,et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.
[109] A. Piccin,et al. Circulating microparticles: pathophysiology and clinical implications. , 2007, Blood reviews.
[110] V. Fuster,et al. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. , 1990, Journal of the American College of Cardiology.
[111] Y. Takada,et al. Plasmin-induced migration requires signaling through protease-activated receptor 1 and integrin alpha(9)beta(1). , 2004, The Journal of biological chemistry.
[112] W. Aird,et al. Thrombin stimulation of vascular adhesion molecule-1 in endothelial cells is mediated by protein kinase C (PKC)-delta-NF-kappa B and PKC-zeta-GATA signaling pathways. , 2003, The Journal of biological chemistry.
[113] K. Kaibuchi,et al. Rho GTPase/Rho Kinase Negatively Regulates Endothelial Nitric Oxide Synthase Phosphorylation through the Inhibition of Protein Kinase B/Akt in Human Endothelial Cells , 2002, Molecular and Cellular Biology.
[114] V. Fuster,et al. Role of Thrombin in Arterial Thrombosis: Implications for Therapy , 1991, Thrombosis and Haemostasis.
[115] J. Hoxie,et al. Structure and function of the human platelet thrombin receptor. Studies using monoclonal antibodies directed against a defined domain within the receptor N terminus. , 1992, The Journal of biological chemistry.
[116] P. Nawroth,et al. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[117] T. Kietzmann,et al. Redox-sensitive regulation of the HIF pathway under non-hypoxic conditions in pulmonary artery smooth muscle cells , 2004, Biological chemistry.
[118] J. A. Barnes,et al. Protease activated receptors in cardiovascular function and disease , 2004, Molecular and Cellular Biochemistry.
[119] B. Binder,et al. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. , 1999, Blood.
[120] V. Yatsula,et al. The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells. , 1996, The Journal of clinical investigation.
[121] M. O’Donnell,et al. Beyond Unfractionated Heparin and Warfarin: Current and Future Advances , 2007, Circulation.
[122] N. Prévost,et al. Thrombin Responses in Human Endothelial Cells , 2000, The Journal of Biological Chemistry.
[123] D. Ku,et al. Expression of thrombin receptors in human atherosclerotic coronary arteries leads to an exaggerated vasoconstrictory response in vitro. , 1997, Journal of cardiovascular pharmacology.
[124] Yuchuan Liu,et al. Thrombin and Tumor Necrosis Factor α Synergistically Stimulate Tissue Factor Expression in Human Endothelial Cells , 2004, Journal of Biological Chemistry.
[125] J. Hamilton,et al. Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries. , 1998, Circulation research.
[126] B. Loriod,et al. Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. , 2006, Blood.
[127] C. Hennekens,et al. Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study). , 2006, The American journal of cardiology.
[128] N. Tsopanoglou,et al. On the mechanism of thrombin-induced angiogenesis: involvement of αvβ3-integrin , 2002 .
[129] S. Karpatkin,et al. Thrombin Induces Increased Expression and Secretion of VEGF from Human FS4 Fibroblasts, DU145 Prostate Cells and CHRF Megakaryocytes , 2001, Thrombosis and Haemostasis.
[130] L. Badimón,et al. Neuron‐derived orphan receptor‐1 (NOR‐1) is induced by thrombin and mediates vascular endothelial cell growth , 2007, Journal of thrombosis and haemostasis : JTH.
[131] R. Busse,et al. Thrombin Activates the Hypoxia-Inducible Factor-1 Signaling Pathway in Vascular Smooth Muscle Cells: Role of the p22phox-Containing NADPH Oxidase , 2001, Circulation research.
[132] B. Kobilka,et al. Intracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor. , 1994, The Journal of biological chemistry.
[133] José A López,et al. The glycoprotein Ib-IX-V complex , 2007 .
[134] T. Cocks,et al. Increased Expression of Protease-Activated Receptor-2 (PAR2) and PAR4 in Human Coronary Artery by Inflammatory Stimuli Unveils Endothelium-Dependent Relaxations to PAR2 and PAR4 Agonists , 2001, Circulation research.
[135] S. Coughlin,et al. Protease-activated Receptors 1 and 4 Are Shut Off with Distinct Kinetics after Activation by Thrombin* , 2000, The Journal of Biological Chemistry.
[136] L. Badimón,et al. Neuron-Derived Orphan Receptor-1 (NOR-1) Modulates Vascular Smooth Muscle Cell Proliferation , 2003, Circulation research.
[137] M. Runge,et al. Thrombin Regulates Vascular Smooth Muscle Cell Growth and Heat Shock Proteins via the JAK-STAT Pathway* , 2001, The Journal of Biological Chemistry.
[138] V. Fuster,et al. Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty. , 1994, Circulation.
[139] L. Badimón,et al. Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi. , 1992, Circulation.
[140] C. Kempton,et al. Novel therapeutic agents in the management of hemorrhage and thrombosis. , 2006, Cardiovascular & hematological agents in medicinal chemistry.